Replies to post #97909 on Ayala Pharmaceuticals Inc (ADXS)

[Bourbon_on_my_cornflakes]

ZACKs VERY positive

Zacks is never wrong

For the full year, our Zacks Consensus Estimates are projecting revenue of $21.72 million, which would represent changes of +258.16% from the prior year.

Investors might also notice recent changes to analyst estimates for ADXS. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook